| Literature DB >> 36252282 |
Jingjing Wu1, Ranran Zhu2, Zhengxia Wang1, Xueqin Chen1, Tingting Xu1, Yanan Liu1, Meijuan Song1, Jingxian Jiang1, Qiyun Ma1, Zhongqi Chen1, Yuan Liu3, Xiaoyue Wang4, Mingshun Zhang5, Mao Huang6, Ningfei Ji7.
Abstract
CD3+CD4-CD8- double-negative T (DNT) cells are new weapons in cancer immunotherapy. Here, we explored DNT cells in malignant pleural effusions (MPEs) from lung cancer patients. DNT cells, especially TCRαβ+CD56- DNT cells, were increased in MPE from lung cancer patients. DNT cells highly expressed PD-1, TRAIL, NKG2D and DNAM-1. In contrast, FasL was barely detected in DNT cells. Compared with non-MPE cells, MPE-derived DNT cells expressed much higher levels of PD-1 and TRAIL. DNT cells from healthy peripheral blood donors potentially killed lung cancers, which was decreased by MPE supernatant. Exosomes from MPE supernatant expressed PD-1 and CEACAM1 and impaired the cytotoxicity of DNT cells. Blocking PD-1 and TIM3 rescued the cytotoxicity of DNT cells treated with MPE-derived exosomes. Overall, we demonstrated that the frequency of DNT cells in MPE from lung cancer patients was increased and that MPE-derived exosomes impaired the cytotoxicity of DNT cells via the PD-1/PD-L1 and CEACAM1/TIM3 pathways.Entities:
Year: 2022 PMID: 36252282 PMCID: PMC9579705 DOI: 10.1016/j.tranon.2022.101564
Source DB: PubMed Journal: Transl Oncol ISSN: 1936-5233 Impact factor: 4.803